Skip to main content

News Archive

News Archive - COVID-19

Rady School of Management at UC San Diego Launches COVID-19 Business Recovery Coalition

May 14, 2020

The Rady School of Management at the University of California San Diego has launched the Rady School Business Recovery Coalition to help businesses in the San Diego region navigate the unprecedented challenges faced by COVID-19.

Introducing the UC San Diego Return to Learn Program

May 5, 2020

Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall.

How are You Doing? Researchers Hope to Measure Well-Being at Global Scale

May 5, 2020

With website, UC San Diego School of Medicine scientists will monitor health and well-being during and after pandemic.

UC San Diego Health Offers Virtual Appointments to Patients with COVID-19

May 4, 2020

UC San Diego Health now offers a telemedicine clinic to help patients with COVID-19 recover at home.

Green Method Could Enable Hospitals to Produce Hydrogen Peroxide In House

May 1, 2020

A team of researchers has developed a portable, more environmentally friendly method to produce hydrogen peroxide. It could enable hospitals to make their own supply of the disinfectant on demand and at lower cost.

Clinical Trial to Investigate whether Hypertension Drug Ameliorates COVID-19 Severity

April 30, 2020

UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

UC San Diego Health Nationally Recognized with ‘A’ Grades for Safety

April 30, 2020

UC San Diego Health has been awarded double ‘A’ grades for the spring 2020 Leapfrog Hospital Safety Grade.

Arthritis Drug Presents Promise as Treatment for COVID-19 Pneumonia

April 29, 2020

UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.

Loss of Smell Associated with Milder Clinical Course in COVID-19

April 27, 2020

Researchers at UC San Diego Health report in newly published findings that olfactory impairment suggests the resulting COVID-19 disease is more likely to be mild to moderate, a potential early indicator that could help health care providers determine which patients may require hospitalization.

Marrying Molecular Farming and Advanced Manufacturing to Develop a COVID-19 Vaccine

April 20, 2020

UC San Diego nanoengineers received a Rapid Response Research (RAPID) grant from the National Science Foundation to develop—using a plant virus—a stable, easy to manufacture COVID-19 vaccine patch that can be shipped around the world and painlessly self-administered by patients.
Category navigation with Social links